0 Bewertungen
ID

39345

Beschreibung

Nimotuzumab in Combination With TPF(Cisplatin ,Fluorouracil and Docetaxel) for Head and Neck Squamous Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01425736

Link

https://clinicaltrials.gov/show/NCT01425736

Stichworte

Versionen (1)
  1. 23.12.19 23.12.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

23. Dezember 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

  • Neueste
  • Älteste
  • Beliebt
  • Neueste
    • Neueste
    • Älteste
    • Beliebt

    Keine Kommentare

    Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

    Eligibility Head and Neck Squamous Cell Carcinoma NCT01425736

    Englisch

    Eligibility Head and Neck Squamous Cell Carcinoma NCT01425736

    1 Formulare  
    Inclusion Criteria
    Beschreibung

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    joined the study voluntary and signed informed consent form
    Beschreibung

    Informed Consent

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0021430
    age 18-75，both genders.
    Beschreibung

    Age

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0001779
    had histologically or cytologically confirmed recurrent or metastatic squamous cell carcinoma of the head and neck
    Beschreibung

    Recurrent Head and Neck Squamous Cell Carcinoma | HEAD NECK CANCER SQUAMOUS CELL METASTATIC

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C4524839
    UMLS CUI [2]
    C0744620
    at least one lesions can be measured,conventional measurements ≥2cm, computed tomography(ct) examination ≥1cm .
    Beschreibung

    Measurable Disease Quantity | Lesion size Measurement conventional | Lesion size Computed Tomography

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C1513041
    UMLS CUI [1,2]
    C1265611
    UMLS CUI [2,1]
    C0449453
    UMLS CUI [2,2]
    C0242485
    UMLS CUI [2,3]
    C0439858
    UMLS CUI [3,1]
    C0449453
    UMLS CUI [3,2]
    C0040405
    eastern cooperative oncology group(ecog) performance scale 0-2.
    Beschreibung

    ECOG performance status

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C1520224
    life expectancy of more than 3 months.
    Beschreibung

    Life Expectancy

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0023671
    use of an effective contraceptive method for women when there is a risk of pregnancy during the study.
    Beschreibung

    Gender | At risk of unplanned pregnancy Contraceptive method

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0079399
    UMLS CUI [2,1]
    C3839721
    UMLS CUI [2,2]
    C0700589
    haemoglobin≥90g/l ,white blood cell(wbc) ≥3×10^9/l
    Beschreibung

    Hemoglobin measurement | White Blood Cell Count procedure

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0518015
    UMLS CUI [2]
    C0023508
    hepatic function:alat、asat< 2.5 x uln, tbil< 1.5 x uln
    Beschreibung

    Liver function | Alanine aminotransferase measurement | Aspartate aminotransferase measurement | Serum total bilirubin measurement

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0232741
    UMLS CUI [2]
    C0201836
    UMLS CUI [3]
    C0201899
    UMLS CUI [4]
    C1278039
    renal function: creatinine < 1.5 x uln
    Beschreibung

    Renal function | Creatinine measurement, serum

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0232804
    UMLS CUI [2]
    C0201976
    Exclusion Criteria
    Beschreibung

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    received other anti egfr monoclonal antibody treatment
    Beschreibung

    Anti-EGFR monoclonal antibody therapy

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C4316122
    participation in other interventional clinical trials within 1 month
    Beschreibung

    Study Subject Participation Status | Interventional procedure

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C2348568
    UMLS CUI [2]
    C0184661
    previous received other drug or operative treatment within 6 month
    Beschreibung

    Pharmacotherapy Other | Operative Surgical Procedure Other

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0013216
    UMLS CUI [1,2]
    C0205394
    UMLS CUI [2,1]
    C0543467
    UMLS CUI [2,2]
    C0205394
    pregnant or breast-feeding women
    Beschreibung

    Pregnancy | Breast Feeding

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0032961
    UMLS CUI [2]
    C0006147
    history of serious allergic or allergy
    Beschreibung

    Hypersensitivity Serious

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0020517
    UMLS CUI [1,2]
    C0205404
    patients with the history of serious lung or head disease
    Beschreibung

    Lung disease Serious | Disorder of head Serious

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0024115
    UMLS CUI [1,2]
    C0205404
    UMLS CUI [2,1]
    C1290856
    UMLS CUI [2,2]
    C0205404
    other malignant tumor
    Beschreibung

    Cancer Other

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C1707251
    not primary tumor(except for primary tumor therapy>3months)
    Beschreibung

    Neoplasm Except Primary tumor

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0027651
    UMLS CUI [1,2]
    C0332300
    UMLS CUI [1,3]
    C0677930
    Zum Seitenanfang zurückkehren

    Ähnliche Modelle

    Eligibility Head and Neck Squamous Cell Carcinoma NCT01425736

    1 Formulare
    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datentyp
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Informed Consent
    Item
    joined the study voluntary and signed informed consent form
    boolean
    C0021430 (UMLS CUI [1])
    Age
    Item
    age 18-75，both genders.
    boolean
    C0001779 (UMLS CUI [1])
    Recurrent Head and Neck Squamous Cell Carcinoma | HEAD NECK CANCER SQUAMOUS CELL METASTATIC
    Item
    had histologically or cytologically confirmed recurrent or metastatic squamous cell carcinoma of the head and neck
    boolean
    C4524839 (UMLS CUI [1])
    C0744620 (UMLS CUI [2])
    Measurable Disease Quantity | Lesion size Measurement conventional | Lesion size Computed Tomography
    Item
    at least one lesions can be measured,conventional measurements ≥2cm, computed tomography(ct) examination ≥1cm .
    boolean
    C1513041 (UMLS CUI [1,1])
    C1265611 (UMLS CUI [1,2])
    C0449453 (UMLS CUI [2,1])
    C0242485 (UMLS CUI [2,2])
    C0439858 (UMLS CUI [2,3])
    C0449453 (UMLS CUI [3,1])
    C0040405 (UMLS CUI [3,2])
    ECOG performance status
    Item
    eastern cooperative oncology group(ecog) performance scale 0-2.
    boolean
    C1520224 (UMLS CUI [1])
    Life Expectancy
    Item
    life expectancy of more than 3 months.
    boolean
    C0023671 (UMLS CUI [1])
    Gender | At risk of unplanned pregnancy Contraceptive method
    Item
    use of an effective contraceptive method for women when there is a risk of pregnancy during the study.
    boolean
    C0079399 (UMLS CUI [1])
    C3839721 (UMLS CUI [2,1])
    C0700589 (UMLS CUI [2,2])
    Hemoglobin measurement | White Blood Cell Count procedure
    Item
    haemoglobin≥90g/l ,white blood cell(wbc) ≥3×10^9/l
    boolean
    C0518015 (UMLS CUI [1])
    C0023508 (UMLS CUI [2])
    Liver function | Alanine aminotransferase measurement | Aspartate aminotransferase measurement | Serum total bilirubin measurement
    Item
    hepatic function:alat、asat< 2.5 x uln, tbil< 1.5 x uln
    boolean
    C0232741 (UMLS CUI [1])
    C0201836 (UMLS CUI [2])
    C0201899 (UMLS CUI [3])
    C1278039 (UMLS CUI [4])
    Renal function | Creatinine measurement, serum
    Item
    renal function: creatinine < 1.5 x uln
    boolean
    C0232804 (UMLS CUI [1])
    C0201976 (UMLS CUI [2])
    Item Group
    C0680251 (UMLS CUI)
    Anti-EGFR monoclonal antibody therapy
    Item
    received other anti egfr monoclonal antibody treatment
    boolean
    C4316122 (UMLS CUI [1])
    Study Subject Participation Status | Interventional procedure
    Item
    participation in other interventional clinical trials within 1 month
    boolean
    C2348568 (UMLS CUI [1])
    C0184661 (UMLS CUI [2])
    Pharmacotherapy Other | Operative Surgical Procedure Other
    Item
    previous received other drug or operative treatment within 6 month
    boolean
    C0013216 (UMLS CUI [1,1])
    C0205394 (UMLS CUI [1,2])
    C0543467 (UMLS CUI [2,1])
    C0205394 (UMLS CUI [2,2])
    Pregnancy | Breast Feeding
    Item
    pregnant or breast-feeding women
    boolean
    C0032961 (UMLS CUI [1])
    C0006147 (UMLS CUI [2])
    Hypersensitivity Serious
    Item
    history of serious allergic or allergy
    boolean
    C0020517 (UMLS CUI [1,1])
    C0205404 (UMLS CUI [1,2])
    Lung disease Serious | Disorder of head Serious
    Item
    patients with the history of serious lung or head disease
    boolean
    C0024115 (UMLS CUI [1,1])
    C0205404 (UMLS CUI [1,2])
    C1290856 (UMLS CUI [2,1])
    C0205404 (UMLS CUI [2,2])
    Cancer Other
    Item
    other malignant tumor
    boolean
    C1707251 (UMLS CUI [1])
    Neoplasm Except Primary tumor
    Item
    not primary tumor(except for primary tumor therapy>3months)
    boolean
    C0027651 (UMLS CUI [1,1])
    C0332300 (UMLS CUI [1,2])
    C0677930 (UMLS CUI [1,3])
    Zum Seitenanfang zurückkehren 

    Hilfe

    Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

    Zum Video